Patents by Inventor Connie Erickson-Miller

Connie Erickson-Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT METHOD
    Publication number: 20200276192
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 3, 2020
    Inventor: Connie ERICKSON-MILLER
  • CANCER TREATMENT METHOD
    Publication number: 20190269678
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: May 21, 2019
    Publication date: September 5, 2019
    Applicant: NOVARTIS AG
    Inventor: Connie ERICKSON-MILLER
  • THROMBOPOIETIN MIMETICS
    Publication number: 20150093356
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: December 11, 2014
    Publication date: April 2, 2015
    Inventor: Connie ERICKSON-MILLER
  • Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes
    Patent number: 8637563
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: January 28, 2014
    Assignee: GlaxoSmithKline LLC
    Inventor: Connie Erickson-Miller
  • THROMBOPOIETIN MIMETICS
    Publication number: 20130078213
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: August 24, 2012
    Publication date: March 28, 2013
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Daniel F. Eppley, Julian Jenkins, Juan I. Luengo, Nannan Liu, Alan T. Price, Antony N. Shaw, Sophie Visonneau, Kenneth Wiggall
  • CANCER TREATMENT METHOD
    Publication number: 20120302579
    Abstract: Invented is a method of treating cancer and pre-cancerous syndromes in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: June 4, 2012
    Publication date: November 29, 2012
    Inventor: Connie Erickson-Miller
  • CANCER TREATMENT METHOD
    Publication number: 20120295918
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: June 4, 2012
    Publication date: November 22, 2012
    Inventor: Connie Erickson-Miller
  • Methods For Treating Degenerative Diseases/Injuries
    Publication number: 20120252855
    Abstract: Invented is a method of treating cardiovascular disease/injury, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: March 1, 2012
    Publication date: October 4, 2012
    Inventors: Connie ERICKSON-MILLER, Julian JENKINS
  • METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20110300630
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: June 9, 2011
    Publication date: December 8, 2011
    Inventors: Connie ERICKSON-MILLER, Julian JENKINS
  • THROMBOPOIETIN MIMETICS
    Publication number: 20110212054
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: August 3, 2010
    Publication date: September 1, 2011
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Julian Jenkins, Juan I. Luengo
  • METHODS OF TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20110184035
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: January 31, 2011
    Publication date: July 28, 2011
    Inventors: Connie Erickson-Miller, Julian Jenkins
  • CANCER TREATMENT METHOD
    Publication number: 20110160130
    Abstract: Invented is a method of treating cancer and pre-cancerous syndromes in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a combination of a non-peptide TPO receptor agonist or a peptide TPO mimetic and a cell cycle signalling inhibitor compound to such mammal.
    Type: Application
    Filed: August 2, 2010
    Publication date: June 30, 2011
    Inventor: Connie ERICKSON-MILLER
  • CANCER TREATMENT METHOD
    Publication number: 20110129550
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist or TPO cell cycle activator and a chemotherapeutic agent to such mammal, suitably a human.
    Type: Application
    Filed: November 17, 2010
    Publication date: June 2, 2011
    Inventor: Connie ERICKSON-MILLER
  • Thrombopoietin mimetics
    Patent number: 7790704
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: September 7, 2010
    Assignee: GlaxoSmithKline, LLC
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Julian Jenkins, Juan I. Luengo
  • Thrombopoietin mimetics
    Patent number: 7648971
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: January 19, 2010
    Assignee: SmithKline Beecham Corp.
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Julian Jenkins, Juan I. Luengo, Sophie Visonneau
  • Methods for Treating Degenerative Diseases/Injuries
    Publication number: 20100004302
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: July 2, 2009
    Publication date: January 7, 2010
    Inventors: Connie ERICKSON-MILLER, Julian Jenkins
  • Methods For Treating Degenerative Diseases/Injuries
    Publication number: 20090298179
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Inventors: Connie ERICKSON-MILLER, Julian Jenkins
  • THROMBOPOIETIN MIMETICS
    Publication number: 20090176973
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: June 18, 2008
    Publication date: July 9, 2009
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Daniel F. Eppley, Julian Jenkins, Juan I. Luengo, Nannan Liu, Alan T. Price, Antony N. Shaw, Sophie Visonneau, Kenneth Wiggall
  • THROMBOPOIETIN MIMETICS
    Publication number: 20090176746
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: June 18, 2008
    Publication date: July 9, 2009
    Inventors: Kevin J Duffy, Connie Erickson-Miller, Daniel F. Eppley, Julian Jenkins, Juan I. Luengo, Nannan Liu, Alan T. Price, Antony N. Shaw, Sophie Visonneau, Kenneth Wiggall
  • THROMBOPOIETIN MIMETICS
    Publication number: 20090155203
    Abstract: Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Application
    Filed: June 18, 2008
    Publication date: June 18, 2009
    Inventors: Kevin J. Duffy, Connie Erickson-Miller, Daniel F. Eppley, Julian Jenkins, Juan I. Luengo, Nannan Liu, Alan T. Price, Antony N. Shaw, Sophie Visonneau, Kenneth Wiggal